ALK-Abelló Nordic

About ALK-Abelló Nordic

ALK-Abelló Nordic is a leading biopharmaceutical company dedicated to the development and production of allergy immunotherapy products. With a strong commitment to improving the quality of life for individuals suffering from allergies, we focus on innovative solutions that address the underlying causes of allergic diseases.

Our core activities include research, development, and manufacturing of a wide range of allergy treatments, including subcutaneous and sublingual immunotherapy. We pride ourselves on our rigorous scientific approach and adherence to the highest standards of quality and safety in all our products.

At ALK-Abelló Nordic, we believe in the power of collaboration. We work closely with healthcare professionals, researchers, and patients to ensure that our therapies meet the needs of those we serve. Our vision is to be at the forefront of allergy treatment, providing effective solutions that empower patients to manage their conditions effectively.

We are also committed to sustainability and corporate responsibility, striving to minimize our environmental impact while maximizing the positive effects of our therapies on public health.

• Innovative Research: Our dedicated team of scientists is constantly exploring new avenues in allergy treatment.
• Patient-Centric Approach: We prioritize the needs and experiences of patients in our product development.
• Global Reach: While based in the Nordic region, our products are available in numerous countries worldwide.

With a rich history and a forward-looking vision, ALK-Abelló Nordic continues to lead the way in allergy immunotherapy, making a significant difference in the lives of millions.